Low-FODMAP diet improves irritable bowel syndrome symptoms: A meta-analysis

Nutrients

Volumn 9, Issue 9, 2017, Pages

  Altobelli, Emma ^a   Del Negro, Valerio ^a   Angeletti, Paolo Matteo ^a   Latella, Giovanni ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Epidemiology; Irritable bowel syndrome; Meta analysis; Nutrition

Indexed keywords

DISACCHARIDE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYOL;

ABDOMINAL PAIN; BLOATING; CARBOHYDRATE DIET; CELIAC DISEASE; CLINICAL OUTCOME; COLITIS; COLORECTAL CANCER; DIET SUPPLEMENTATION; DISPERSITY; FECES ANALYSIS; HUMAN; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; LACTOBACILLUS; LACTOSE TOLERANCE; LOW CARBOHYDRATE DIET; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; COHORT ANALYSIS; DEFECATION; DIET THERAPY; EVIDENCE BASED MEDICINE; FERMENTATION; GASTROINTESTINAL TRACT; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ABDOMINAL PAIN; COHORT STUDIES; DEFECATION; DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; EVIDENCE-BASED MEDICINE; FERMENTATION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; OLIGOSACCHARIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 85028437593     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9090940     Document Type: Review

References (66)

1. Altobelli, E.; Lattanzi, A.; Paduano, R.; Varrassi, G.; di Orio, F. Colorectal cancer prevention in Europe: Burden of disease and status of screening programs. Prev. Med. 2014, 62, 132–141. [CrossRef] [PubMed]
2. Altobelli, E.; D’Aloisio, F.; Angeletti, P.M. Colorectal cancer screening in countries of European Council outside of the EU-28. World J. Gastroenterol. 2016, 22, 4946–4957. [CrossRef]
3. Burisch, J.; Jess, T.; Martinato, M.; Lakatos, P.L. ECCO-EpiCom. The burden of inflammatory bowel disease in Europe. J. Crohn’s Colitis 2013, 7, 322–337. [CrossRef] [PubMed]
4. American College of Gastroenterology Task Force on Irritable Bowel Syndrome; Brandt, L.J.; Chey, W.D.; Foxx-Orenstein, A.E.; Schiller, L.R.; Schoenfeld, P.S.; Spiegel, B.M.; Talley, N.J.; Quigley, E.M. An evidence-based position statement on the management of irritable bowel syndrome. Am. J. Gastroenterol. 2009, 104, S1–S35. [CrossRef] [PubMed]
5. Andrews, E.B.; Eaton, S.C.; Hollis, K.A.; Hopkins, J.S.; Ameen, V.; Hamm, L.R.; Cook, S.F.; Tennis, P.; Mangel, A.W. Prevalence and demographics of irritable bowel syndrome: Results from a large web-based survey. Aliment. Pharmacol. Ther. 2005, 22, 935–942. [CrossRef] [PubMed]
6. Müller-Lissner, S.A.; Bollani, S.; Brummer, R.J.; Coremans, G.; Dapoigny, M.; Marshall, J.K.; Muris, J.W.; Oberndorff-Klein, W.A.; Pace, F.; Rodrigo, L.; et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001, 64, 200–204. [CrossRef] [PubMed]
7. El-Salhy, M.; Gundersen, D.; Gilja, O.H.; Hatlebakk, J.G.; Hausken, T. Is irritable bowel syndrome an organic disorder? World J. Gastroenterol. 2014, 20, 384–400. [CrossRef] [PubMed]
8. Horwitz, B.J.; Fisher, R.S. The irritable bowel syndrome. N. Engl. J. Med. 2001, 344, 1846–1850. [CrossRef] [PubMed]
9. Chang, L. Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment. Pharmacol. Ther. 2004, 20, 31–39. [CrossRef] [PubMed]
10. Maxion-Bergemann, S.; Thielecke, F.; Abel, F.; Bergemann, R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006, 24, 21–37. [CrossRef] [PubMed]
11. Chey, W.D.; Kurlander, J.; Eswaran, S. Irritable bowel syndrome: A clinical review. JAMA 2015, 313, 949–958. [CrossRef] [PubMed]
12. Anastasi, J.K.; Capili, B.; Chang, M. Managing irritable bowel syndrome. Am. J. Nurs. 2013, 113, 42–52. [CrossRef] [PubMed]
13. Mayer, E.A. Clinical practice. Irritable bowel syndrome. N. Engl. J. Med. 2008, 358, 1692–1699. [CrossRef] [PubMed]
14. Mayer, E.A.; Labus, J.S.; Tillisch, K.; Cole, S.W.; Baldi, P. Towards a system view of IBS. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 592–605. [CrossRef] [PubMed]
15. Rajilić-Stojanović, M.; Jonkers, D.M.; Salonen, A.; Hanevik, K.; Raes, J.; Jalanka, J.; de Vos, W.M.; Manichanh, C.; Golic, N.; Enck, P.; et al. Intestinal microbiota and diet in IBS: Causes, consequences, or epiphenomena? Am. J. Gastroenterol. 2015, 110, 278–287. [CrossRef] [PubMed]
16. Böhn, L.; Störsrud, S.; Simrén, M. Nutrient intake in patients with irritable bowel syndrome compared with the general population. Neurogastroenterol. Motil. 2013, 25, 23–30. [CrossRef] [PubMed]
17. Hayes, P.A.; Fraher, M.H.; Quigley, E.M. Irritable bowel syndrome: The role of food in pathogenesis and management. Gastroenterol. Hepatol. 2014, 10, 164–174.
18. Eswaran, S.; Tack, J.; Chey, W.D. Food: The forgotten factor in the irritable bowel syndrome. Gastroenterol. Clin. N. Am. 2011, 40, 141–162. [CrossRef] [PubMed]
19. Farré, R.; Tack, J. Food and symptom generation in functional gastrointestinal disorders: Physiological aspects. Am. J. Gastroenterol. 2013, 108, 698–706. [CrossRef] [PubMed]
20. Moayyedi, P.; Ford, A.C.; Quigley, E.M.; Lembo, A.J.; Saito, Y.A.; Schiller, L.R.; Soffer, E.E.; Spiegel, B.M.; Quigley, E.M. Task Force on the Management of Functional Bowel Disorders. The American College of Gastroenterology irritable bowel syndrome monograph: Translating systematic review data to clinical practice. Gastroenterology 2010, 138, 789–791. [CrossRef] [PubMed]
21. Dalrymple, J.; Bullock, I. Diagnosis and management of irritable bowel syndrome in adults in primary care: Summary of NICE guidance. BMJ 2008, 336, 556–568. [CrossRef] [PubMed]
22. Tuck, C.J.; Muir, J.G.; Barrett, J.S.; Gibson, P.R. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: Role in irritable bowel syndrome. Expert Rev. Gastroenterol. Hepatol. 2014, 8, 819–834. [CrossRef] [PubMed]
23. Gibson, P.R.; Varney, J.; Malakar, S.; Muir, J.G. Food components and irritable bowel syndrome. Gastroenterology 2015, 148, 1158–1574. [CrossRef] [PubMed]
24. Barrett, J.S.; Gearry, R.B.; Muir, J.G.; Irving, P.M.; Rose, R.; Rosella, O.; Haines, M.L.; Shepherd, S.J.; Gibson, P.R. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment. Pharmacol. Ther. 2010, 31, 874–882. [CrossRef] [PubMed]
25. Ong, D.K.; Mitchell, S.B.; Barrett, J.S.; Shepherd, S.J.; Irving, P.M.; Biesiekierski, J.R.; Smith, S.; Gibson, P.R.; Muir, J.G. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J. Gastroenterol. Hepatol. 2010, 25, 1366–1373. [CrossRef] [PubMed]
26. Halmos, E.P.; Power, V.A.; Shepherd, S.J.; Gibson, P.R.; Muir, J.G. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014, 146, 67–75. [CrossRef] [PubMed]
27. Shepherd, S.J.; Lomer, M.C.; Gibson, P.R. Short-chain carbohydrates and functional gastrointestinal disorders. Am. J. Gastroenterol. 2013, 108, 707–717. [CrossRef] [PubMed]
28. Camilleri, M.; Boeckxstaens, G. Dietary and pharmacological treatment of abdominal pain in IBS. Gut 2017, 66, 966–974. [CrossRef] [PubMed]
29. Böhn, L.; Störsrud, S.; Liljebo, T.; Collin, L.; Lindfors, P.; Törnblom, H.; Simrén, M. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology 2015, 149, 1399–1407. [CrossRef] [PubMed]
30. Eswaran, S.L.; Chey, W.D.; Han-Markey, T.; Ball, S.; Jackson, K. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol. 2016, 111, 1824–1832. [CrossRef] [PubMed]
31. Laatikainen, R.; Koskenpato, J.; Hongisto, S.M.; Loponen, J.; Poussa, T.; Hillilä, M.; Korpela, R. Randomised clinical trial: Low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Aliment. Pharmacol. Ther. 2016, 44, 460–470. [CrossRef] [PubMed]
32. Gibson, P.R. The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: Is it ready for prime time as a first-line therapy? J. Gastroenterol. Hepatol. 2017, 32, 32–35. [CrossRef] [PubMed]
33. Gibson, P.R.; Shepherd, S.J. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J. Gastroenterol. Hepatol. 2010, 25, 252–258. [CrossRef] [PubMed]
34. Valeur, J.; Røseth, A.G.; Knudsen, T.; Malmstrøm, G.H.; Fiennes, J.T.; Midtvedt, T.; Berstad, A. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. Digestion 2016, 94, 50–56. [CrossRef] [PubMed]
35. Hustoft, T.N.; Hausken, T.; Ystad, S.O.; Valeur, J.; Brokstad, K.; Hatlebakk, J.G.; Lied, G.A. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol. Motil. 2017. [CrossRef] [PubMed]
36. Staudacher, H.M.; Lomer, M.C.; Anderson, J.L.; Barrett, J.S.; Muir, J.G.; Irving, P.M.; Whelan, K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J. Nutr. 2012, 142, 1510–1518. [CrossRef] [PubMed]
37. Staudacher, H.M.; Irving, P.M.; Lomer, M.C.; Whelan, K. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 256–266. [CrossRef] [PubMed]
38. Staudacher, H.M.; Whelan, K. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: Probiotics, prebiotics and the low FODMAP diet. Proc. Nutr. Soc. 2016, 75, 306–318. [CrossRef] [PubMed]
39. Chumpitazi, B.P.; Cope, J.L.; Hollister, E.B.; Tsai, C.M.; McMeans, A.R.; Luna, R.A.; Versalovic, J.; Shulman, R.J. Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2015, 42, 418–427. [CrossRef] [PubMed]
40. Marsh, A.; Eslick, E.M.; Eslick, G.D. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur. J. Nutr. 2016, 55, 897–906. [CrossRef] [PubMed]
41. Moher, D.; Altman, D.G.; Liberati, A.; Tetzlaff, J. PRISMA statement. Epidemiology 2011, 22, 128. [CrossRef] [PubMed]
42. Higgins, J.P.T.; Green, S.; Altman, D.G. Assessing Risk of Bias in Included Studies Published Online. In Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series Chapter 8; WILEY: Hoboken, NJ, USA, 2008.
43. Wells, G.A.; Shea, B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2001. Available online: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed on 31 March 2017).
44. Rothstein, H.R.; Sutton, A.J.; Borenstein, M. Publication Bias in Meta-Analysis; Wiley: Chichester, UK, 2005.
45. Fragkos, K.C.; Tsagris, M.; Frangos, C.C. Publication bias in meta-analysis: Confidence intervals for Rosenthal’s fail-safe number. Int. Sch. Res. Not. 2014, 2014, 825383. [CrossRef] [PubMed]
46. Pedersen, N.; Andersen, N.N.; Végh, Z.; Jensen, L.; Ankersen, D.V.; Felding, M.; Simonsen, M.H.; Burisch, J.; Munkholm, P. Ehealth: Low FODMAP diet vs. Lactobacillus rhamnosus GG in irritable bowel syndrome. World J. Gastroenterol. 2014, 20, 16215–16226. [CrossRef] [PubMed]
47. Peters, S.L.; Yao, C.K.; Philpott, H.; Yelland, G.W.; Muir, J.G.; Gibson, P.R. Randomized clinical trial: The efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment. Pharmacol. Ther. 2016, 44, 447–459. [CrossRef] [PubMed]
48. Major, G.; Pritchard, S.; Murray, K.; Yelland, G.W.; Muir, J.G.; Gibson, P.R. Colon Hypersensitivity to Distension, Rather than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals with Irritable Bowel Syndrome. Gastroenterology 2017, 152, 124–133. [CrossRef] [PubMed]
49. Biesiekierski, J.R.; Peters, S.L.; Newnham, E.D.; Tsai, C.M.; McMeans, A.R.; Luna, R.A.; Versalovic, J.; Shulman, R.J. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013, 145, 320–328. [CrossRef] [PubMed]
50. Whigham, L.; Joyce, T.; Harper, G.; Irving, P.M.; Staudacher, H.M.; Whelan, K.; Lomer, M.C. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J. Hum. Nutr. Diet. 2015, 28, 687–696. [CrossRef] [PubMed]
51. Maagaard, L.; Ankersen, D.V.; Végh, Z.; Burisch, J.; Jensen, L.; Pedersen, N.; Munkholm, P. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J. Gastroenterol. 2016, 22, 4009–4019. [CrossRef] [PubMed]
52. Pedersen, N. EHealth: Self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS. Dan. Med. J. 2015, 62, B5168. [CrossRef] [PubMed]
53. McIntosh, K.; Reed, D.E.; Schneider, T.; Dang, F.; Keshteli, A.H.; De Palma, G.; Madsen, K.; Bercik, P.; Vanner, S. FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial. Gut 2016, 66, 1241–1251. [CrossRef] [PubMed]
54. De Roest, R.H.; Dobbs, B.R.; Chapman, B.A.; Batman, B.; O’Brien, L.A.; Leeper, J.A.; Hebblethwaite, C.R.; Gearry, R.B. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int. J. Clin. Pract. 2013, 67, 895–903. [CrossRef] [PubMed]
55. Huamán, J.W.; Felip, A.; Guedea, E.; Jansana, M.; Videla, S.; Saperas, E. The diet low in fermentable carbohydrates short chain and polyols improves symptoms in patients with functional gastrointestinal disorders in Spain. Gastroenterol. Hepatol. 2015, 38, 113–122. [CrossRef] [PubMed]
56. López, N.P.Y.; Torres-López, E.; Zamarripa-Dorsey, F. Clinical response in Mexican patients with irritable bowel syndrome treated with a low diet low in fermentable carbohydrates (FODMAP). Rev. Gastroenterol. Mex. 2015, 80, 180–185.
57. Mazzawi, T.; Hausken, T.; Gundersen, D.; El-Salhy, M. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur. J. Clin. Nutr. 2016, 70, 175–181. [CrossRef] [PubMed]
58. Staudacher, H.M.; Whelan, K.; Irving, P.M.; Lomer, M.C. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J. Hum. Nutr. Diet. 2011, 24, 487–495. [CrossRef] [PubMed]
59. Gibson, P.R. Use of the low-FODMAP diet in inflammatory bowel disease. J. Gastroenterol. Hepatol. 2017, 32, 40–42. [CrossRef] [PubMed]
60. Nanayakkara, W.S.; Skidmore, P.M.; O’Brien, L.; Wilkinson, T.J.; Gearry, R.B. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: The evidence to date. Clin. Exp. Gastroenterol. 2016, 9, 131–142. [PubMed]
61. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 2009, 62, e1–e34. [CrossRef] [PubMed]
62. O’Keeffe, M.; Jansen, C.; Martin, L.; Williams, M.; Seamark, L.; Staudacher, H.M.; Irving, P.M.; Whelan, K.; Lomer, M.C. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterol. Motil. 2017. [CrossRef] [PubMed]
63. Irritable Bowel Syndrome in Adults: Diagnosis and Management. Available online: https://www.nice.org. uk/guidance/cg61 (accessed on 1 July 2017).
64. Staudacher, H.M.; Lomer, M.C.E.; Farquharson, F.M.; Louis, P.; Fava, F.; Franciosi, E.; Scholz, M.; Tuohy, K.M.; Lindsay, J.O.; Irving, P.M.; et al. Diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores bifidobacterium species: A randomized controlled trial. Gastroenterology 2017. [CrossRef] [PubMed]
65. Catassi, G.; Lionetti, E.; Gatti, S.; Catassi, C. The low FODMAP diet: Many question marks for a catchy acronym. Nutrients 2017, 9, E292. [CrossRef] [PubMed]
66. Vincenzi, M.; Del Ciondolo, I.; Pasquini, E.; Gennai, K.; Paolini, B. Effects of a low FODMAP diet and specific carbohydrate diet on symptoms and nutritional adequacy of patients with irritable bowel syndrome: Preliminary results of a single-blinded randomized trial. J. Transl. Int. Med. 2017, 30, 120–126. [CrossRef] [PubMed]